NCT07320066 (IMT in Asthma) is a clinical trial of other in Qualitative Research, sponsored by Istanbul Esenyurt University.

Who is sponsoring NCT07320066?

NCT07320066 is sponsored by Istanbul Esenyurt University.

What drugs are being tested in NCT07320066?

Interventions in NCT07320066: other.

What condition does NCT07320066 study?

NCT07320066 studies Qualitative Research.

Is NCT07320066 still recruiting?

NCT07320066 is currently recruiting now. Last updated 9 January 2026.

Last reviewed 2026-01-09 · How we verify

NCT07320066: IMT in Asthma

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

IMT in Asthma: Activity, Coping, Self-Management

Recruiting now Last updated 9 January 2026

What this trial tests

trial testing other in Qualitative Research in 15 participants. Currently enrolling.

Timeline

5 January 2026

Primary endpoint
1 January 2027

19 December 2027

Quick facts

Lead sponsor	Istanbul Esenyurt University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	15
Start date	5 January 2026
Primary completion	1 January 2027
Estimated completion	19 December 2027
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

other

Conditions studied

Qualitative Research — all drugs for Qualitative Research →

Sponsor

Istanbul Esenyurt University

Who can join

Adults 18 to 65, any sex, with Qualitative Research. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate asthma patients' experiences with an 8 week IMT and the perceived effects of this intervention on physical activity, coping strategies, and asthma self-management. A qualitative methodological design will be applied to understand the experiences of patients participating in the IMT program, how the program affected their daily activities, how they coped with symptoms and difficulties, and how they managed their condition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of other

Trials testing the same drug.

NCT07380620 — Stepwise Strategy for Treatment of Atrial Fibrillation Substrate Extended Study · enrolling by invitation
NCT07389785 — Age Related Chromatin Remodelling as a Therapeutic Target for Organ Protection in Cardiac Surgery · active not recruiting
NCT06729710 — Prism Adaptation in Symptomatic Esophoria - Effect of Shorter Time Intervals and Surgical Outcomes Based on Prism Adapta · NA · recruiting
NCT06499636 — In Vitro Models From Pediatric Brain Tumors · not yet recruiting
NCT06391320 — Obesity Queue Database · recruiting

Other recruiting trials for Qualitative Research

Currently open trials in the same condition.

NCT07444411 — Connect Qualitative Interviews · active not recruiting
NCT07074899 — Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru · NA · active not recruiting
NCT06702579 — Home Monitoring in Hemophilia a · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07320066 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Esenyurt University
Last refreshed: 9 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07320066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing